Chronic Venus Ulcer Study (allo-APZ2-CVU)

Full Title: A pivotal, randomized, placebo-controlled, double-blind, multicenter, international Phase III clinical trial is designed to investigate the efficacy and safety of ALLO-APZ2-CVU in promoting wound healing in patients with therapy-resistant, non-healing chronic venous ulcers (CVUs).

Aim: To evaluate the efficacy and safety of topically administered allo-APZ2-CVU compared to a placebo. This study aims to improve treatment outcomes for patients suffering from therapy-resistant CVUs

If you think you have any patients eligible for this study please email hcl.trials@nhs.net

You can read more about FAQs about this study here